SCHEMBL28839375

SCHEMBL28839375

O=C(c1ccc(-c2cncc(-c3ccccc3)n2)cc1)N1CCNCC1

nearest known ligand 0.64

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
MKNK2 Q9HBH9 3/20 0.64
MKNK1 Q9BUB5 2/20 0.64
SIGMAR1 Q99720 1/20 0.61
ATR Q13535 6/20 0.60
CCNC P24863 7/20 0.58
CDK8 P49336 7/20 0.58
KCNH2 Q12809 1/20 0.53
HPGD P15428 1/20 0.52
MAPK1 P28482 1/20 0.52
RIPK1 Q13546 1/20 0.50
EIF4E P06730 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16420512 0.89 ATR (0.71) MKNK2MKNK1SIGMAR1ATRCCNC
SCHEMBL5266293 0.84 SIGMAR1 (0.80) MKNK2MKNK1SIGMAR1CCNCCDK8
SCHEMBL16420762 0.84 CCNC (0.68) ATRCCNCCDK8
SCHEMBL18766571 0.84 MKNK2 (0.55) MKNK2MKNK1ATRCCNCCDK8
SCHEMBL18766582 0.84 MKNK2 (0.55) MKNK2MKNK1ATRCCNCCDK8
Hydrochloric Acid SCHEMBL4763940 0.83 SIGMAR1 (0.77) MKNK2MKNK1SIGMAR1CCNCCDK8
SCHEMBL28125681 0.79 ACACB (0.66) ATR
SCHEMBL894920 0.78 SIGMAR1 (1.00) MKNK2MKNK1SIGMAR1CCNCCDK8
SCHEMBL28393 0.78 SIGMAR1 (1.00) MKNK2MKNK1SIGMAR1CCNCCDK8
SCHEMBL8260488 0.78 SIGMAR1 (0.72) MKNK2MKNK1SIGMAR1CCNCCDK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106518856-A Pyrazine derivatives useful as inhibitors of ATR kinase 沃泰克斯药物股份有限公司 2017-03-22 CN disclosed
CN-106496210-A It is used as the compound of ATR kinase inhibitors 沃泰克斯药物股份有限公司 2017-03-15 CN disclosed
CN-106496209-A It is used as the compound of ATR kinase inhibitors 沃泰克斯药物股份有限公司 2017-03-15 CN disclosed